Pramiverine (HCl)

Pramiverine (HCl) used as an antispasmodic.


Adult Dose
Dose: 2.5 to 5 mg
Single Dose: 3.8 (3.75)
Frequency: As recommended.
Route: IM,Slow IV
Instructions: As Required
Neonatal
Paedriatic
Characteristics
belongs to Phenylcyclohexylamine. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics and Antispasmodic Agent pharmacological group.The Molecular Weight of Pramiverine (HCl) is 329.90.
Contraindications
Pramiverine (HCl) is contraindicated in conditions like Glucoma,Urinary retention (adynamic bladder),Prostatic hypertrophy,Mega colon,Intestinal obstruction.
Effects
No data regarding the side effects produced by Pramiverine (HCl) is available
Indications
Pramiverine (HCl) is primarily indicated in conditions like Colic, GI motality disorder, Pain, Smooth muscle spasm.
Interactions
No data regarding the interactions of Pramiverine (HCl) was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
No data regarding the Warnings/Precuations of Pramiverine (HCl) is available.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.